In breast cancers, ARF3 upregulation was reported as associated with pro-proliferative functions (Huang et al., 2019), while in gastric cancer, similar to our findings in prostate cells, ARF3 suppressed proliferative function and in vivo tumorigenesis (Liu et al., 2021). Here, ARF3 is linked to gastric cancer.